Reg D 506(c) · Investor Overview
Pre-Series A · Round Open
Watch InteliGel®
Transform the Field.
Real trials. Real farmers. Real results — documented across 12 states and 3 land-grant universities.
50%
Less Water
Per Acre
Per Acre
79%
More Crop
Yield
Yield
280%
Average ROI
Year One
Year One
Request Investment Materials
Accredited investors only. Private placement memorandum available upon qualification.
Round Currently Open
Reg D 506(c) · Accredited Investors Only · Limited Allocation
Reg D 506(c) · Accredited Investors Only · Limited Allocation
The Problem
Agriculture is Being Squeezed
Agriculture is Being Squeezed
From Every Direction.
American farmers face compounding crises — degraded soil, skyrocketing input costs, and water inefficiency that threatens viability for the next generation.
−61%
Soil Quality Decline
U.S. farmland has lost more than 60% of its topsoil organic matter over the last century, reducing yields and increasing input dependency across all crop categories.
$500–$5,000
Per-Acre Input Costs
Fertilizer, pesticide, and irrigation costs have surged, squeezing margins to near zero for commodity crops in many regions while debt obligations mount.
52×
Water Inefficiency
Conventional irrigation delivers water 52× less efficiently than biological absorption, with up to 70% lost to evaporation before reaching root zones.
$3,000+
Average Annual Loss Per Farm
The average American farm now operates at a net loss after accounting for debt service, input costs, and price volatility in commodity markets.
The Solution
InteliGel® Transforms How Crops
3,000×
Water Retention Capacity vs. Conventional Soil
InteliGel® Transforms How Crops
Absorb, Retain & Use Water.
A patented polymer matrix applied directly to the soil root zone — holding 3,000 times its weight in water and releasing it precisely when crops need it most.
Up to 79%
Increase in crop yield documented across university trials
50%
Reduction in water usage per acre over the growing season
280%
Average ROI for farmers in year one of application
Bio-Safe
USDA-validated, non-toxic, biodegradable polymer matrix
University of Nebraska Field Trials
3-year longitudinal study confirming yield improvements and water savings across corn, soy, and wheat
USDA Validation Program
Full bio-safety certification and environmental impact assessment completed, approved for commercial use
12-State Commercial Rollout
Active deployments across the primary agricultural belt with documented farmer testimonials and performance data
Patented Polymer Technology
Proprietary crosslinked hydrogel matrix with 14 defensive patent filings protecting the core formulation
Traction
The Numbers Don't Lie.
Proof of demand, real revenue, and a growing footprint across America's farmland.
0+
Farm trials completed across 12 states with documented results
$0M
Documented revenue pipeline from distributors and co-ops
0+
Farmers actively requesting product — demand exceeds capacity
0
States with active distribution interest and purchase intent
"I was skeptical — I've been farming this land for 30 years. But after year one with InteliGel, my corn yield jumped 62% and my water bill dropped by half. I've already pre-ordered for next season."
JAMES WHITFIELD — Corn & Soybean Farmer, Nebraska · 840 Acres
"We ran a side-by-side trial on 200 acres — half treated, half control. The treated section outperformed by nearly 70%. My agronomist said he'd never seen anything like it in his career."
LISA TORRES — Row Crop Producer, Kansas · 1,200 Acres
Farmer Economics
The ROI Case Is
The ROI Case Is
Mathematically Undeniable.
InteliGel® doesn't just save water — it pays for itself many times over in year one.
Cost Comparison Per Acre — Annual
| Line Item | Conventional | InteliGel® |
|---|---|---|
| Irrigation Cost | $380 | $190 |
| Fertilizer Input | $220 | $154 |
| Water Hauling / Labor | $140 | $60 |
| Crop Loss to Drought | $310 | $31 |
| InteliGel® Application | — | $120 |
| Total Annual Cost | $1,050 | $555 |
Year-One ROI Model — Per 100 Acres
| Metric | Without InteliGel | With InteliGel® |
|---|---|---|
| Gross Yield Revenue | $48,000 | $85,920 |
| Total Input Costs | $105,000 | $55,500 |
| Net Margin | −$57,000 | $30,420 |
| ROI on Treatment Cost | — | 280% |
| Water Saved (gallons) | — | 1.2M gal |
Revenue Model
A $300M Single-Facility Revenue
A $300M Single-Facility Revenue
Model. 30 Facilities Planned.
Each production facility generates $300M in annual revenue at scale. We are building 30.
$300M
Annual revenue per production facility at full capacity
~$900M
Projected annual revenue from first 3 facilities (Years 1–3)
30
Total facilities planned across the United States over 5 years
5-Year Growth Schedule
| Year | Facilities | Revenue | EBITDA | Valuation | Per Share |
|---|---|---|---|---|---|
| Y1 | 1 | $12M | $3.2M | $120M | $1,836 |
| Y2 | 3 | $68M | $22M | $340M | $5,202 |
| Y3 | 8 | $190M | $76M | $760M | $11,628 |
| Y4 | 18 | $420M | $189M | $1.89B | $28,931 |
| Y5 | 30 | $900M | $495M | $4.95B | $891,756 |
Financial Projections
5-Year Growth Projection
Revenue and valuation trajectory based on facility rollout plan and current market penetration rates.
Validation
Proven Across America's
Proven Across America's
Agricultural Heartland.
-
University of Nebraska — Lincoln 3-year trial study, 800+ acres, confirmed 79% yield increase in corn and soybean varieties
-
Kansas State University Agronomy Dept. Independent verification of water retention data; endorsed for wheat and sorghum applications
-
Iowa State University Extension On-farm research confirming soil health improvements and input cost reduction metrics
-
USDA NRCS Program Endorsement Bio-safe designation and inclusion in voluntary conservation program recommendations
-
175+ Commercial Farm Customers Verified repeat customers across 12 states with documented performance data on file
Kansas
Nebraska
Iowa
Texas
Georgia
California
Colorado
Ohio
Minnesota
Tennessee
Oregon
North Carolina
Market Opportunity
A Multi-Trillion Dollar
A Multi-Trillion Dollar
Market Waiting to be Captured.
InteliGel® addresses every layer of the global agricultural value chain — from soil health to water infrastructure.
$808B
U.S. Agricultural Market
Total annual value of U.S. crop production — InteliGel's addressable domestic market for direct farmer sales
$27T+
Global Agricultural Market
Total global addressable market across all crop categories — with water scarcity intensifying demand in every region
$300B
Water Technology Market
Global water efficiency and conservation technology segment projected to reach $300B+ by 2030 per OECD estimates
$1B+
Comparable acquisitions in agricultural biotechnology validate a clear path to a billion-dollar exit within the 5-year window.
Bayer Crop Science × Monsanto
$63B
Acquisition of agtech platform with proprietary biological input formulations, 2018
BASF Agricultural Solutions
$7.6B
Acquisition of Bayer seed and trait business with soil health product portfolio
Corteva Agriscience IPO
$14B+
DowDuPont agtech spinout valued at $14B at listing based on biological input platform
The Investment Case
Six Reasons Sophisticated
Six Reasons Sophisticated
Investors Are Moving Now.
I
Patented Technology Moat
14 defensive patent filings protect the core polymer formulation and application methods — creating a defensible position competitors cannot easily replicate.
II
Proven, Documented Results
Unlike most agtech, InteliGel® has 3 years of university-verified trial data across 12 states — not projections, not pilots, but documented commercial-scale results.
III
Scalable Manufacturing Model
Each $300M-revenue production facility is modular and replicable. The 30-facility roadmap creates compounding revenue growth with predictable unit economics.
IV
Massive, Underserved Market
The $808B U.S. agricultural market has seen virtually no biological innovation in soil-water management in decades. InteliGel® enters a greenfield opportunity with first-mover advantage.
V
Aligned, Experienced Team
Leadership includes former Fortune 500 executives, PhD-level agronomists, and senior revenue officers — many of whom have personally invested alongside outside investors.
VI
Pre-Series A Entry Pricing
Investors entering at this round gain access at a valuation that projects 400–500× return at a $4.95B Year-5 exit, with meaningful warrant coverage and preferred equity protections.
Intellectual Property
A Deep, Defensive
A Deep, Defensive
Patent Moat.
-
US-001
Core Polymer Matrix Formulation Crosslinked hydrophilic polymer chain with proprietary crosslinking agent ratios and molecular weight distribution
-
US-002
Agricultural Application Method Soil incorporation technique including depth, concentration, and timing parameters for optimal root-zone water availability
-
US-003
Nutrient Delivery Enhancement Slow-release nutrient co-encapsulation within polymer matrix enabling simultaneous water retention and fertilizer delivery
-
US-004
Biodegradation Pathway Controlled biodegradation chemistry ensuring full soil safety and USDA compliance without residual polymer accumulation
-
PCT-01
International PCT Application Global protection covering 142 PCT member nations for core formulation and manufacturing process, filed 2024
Why the Moat Is Deep
InteliGel's patent portfolio was built with clearance opinions from top-5 IP firms. The formulation took 11 years to develop — competitors cannot shortcut the chemistry or the regulatory path.
Our polymer synthesis process is proprietary and maintained as a trade secret alongside patent protections, creating a layered defensive strategy that is exceptionally difficult to design around.
14
Filed Patents
11yr
R&D Investment
142
PCT Countries
$0
IP Challenges Filed
Leadership
Built by Operators.
Built by Operators.
Backed by Believers.
Our team brings Fortune 500 experience, deep agricultural science, and skin in the game.
Argina Mardiyan
Co-CEO & Co-Founder
Zarzand Alaverdyan
Co-CEO & Co-Founder
Aris Alaverdyan
Chief Science Officer
Dr. Chad Godsey
Chief Agronomist
Jon Licata
Chief Revenue Officer
Investor
Alec Ibach
VP of Market Development
Investor
Nathan Hartman
VP of Business Development
Investor
Justin Ogle
Strategic Advisor, Grower & Distribution
Investor
Argina Mardiyan
Co-CEO & Co-Founder
Zarzand Alaverdyan
Co-CEO & Co-Founder
Aris Alaverdyan
Chief Science Officer
Dr. Chad Godsey
Chief Agronomist
Jon Licata
Chief Revenue Officer
Investor
Alec Ibach
VP of Market Development
Investor
Nathan Hartman
VP of Business Development
Investor
Justin Ogle
Strategic Advisor, Grower & Distribution
Investor
As Featured In
The Story Is Getting Out.
Independent journalists and editors are covering what farmers are already experiencing in the field.
Farm News Daily
we're seeing multi multi year benefit from applications which is which is huge.
Read the Article
Authority Magazine · Medium
Don't ask investors to believe in you. Show them something they can verify independently.
Read the Article
Morning Ag Clips
Water management is no longer just a drought issue. It is a profit issue.
Read the Article
Risk Factors
Material Risks to Consider
Material Risks to Consider
Before Investing.
This is a private placement in an early-stage company. Understand the risks before making a commitment.
Early Stage Company
Green Evolution Technologies is pre-Series A with limited operating history. Past performance in trial phases does not guarantee future commercial results at scale.
Illiquid Investment
This is an illiquid private placement. There is no secondary market for these securities and you may not be able to sell your interest for an extended period or at all.
Manufacturing Scale Risk
The 30-facility production plan requires substantial capital, operational expertise, and execution. Delays or cost overruns could materially impact projected timelines and returns.
Regulatory Environment
Changes to USDA, EPA, or state-level agricultural regulations could impact product approvals, marketing claims, or distribution channels in key markets.
Market Adoption
Farmer adoption of new soil amendments can be slow due to risk aversion and established purchasing habits. Revenue projections depend on achieving significant market penetration.
Competition & IP
Larger agricultural companies with greater resources may develop competing products. Patent protection may be challenged or may not prevent all forms of competitive entry.
FAQ
Common Investor Questions.
This offering is available exclusively to accredited investors as defined under SEC Rule 501 of Regulation D. An accredited investor is generally an individual with net worth exceeding $1 million (excluding primary residence), or annual income exceeding $200,000 ($300,000 joint) in the two most recent years. Institutional investors meeting applicable thresholds are also eligible. You will be required to self-certify and/or provide documentation of accredited status before receiving investment materials.
The minimum investment in this round is $25,000. This threshold is set to ensure investor suitability and operational efficiency in managing the investor base. Investments above $100,000 receive additional warrant coverage as part of the offering terms. Please request the Private Placement Memorandum for full details on share classes, preferences, and warrant structures.
Investors in this round receive preferred equity shares in Green Evolution Technologies, Inc. with standard protective provisions including anti-dilution rights, pro-rata participation in future rounds, and information rights. Investors above certain thresholds also receive warrant coverage exercisable at a fixed strike price. Full terms are detailed in the Private Placement Memorandum available to qualified investors.
Capital raised in this round is allocated as follows: approximately 55% to construction and commissioning of the first production facility; 20% to sales, marketing, and channel development; 15% to working capital and operational runway; and 10% to R&D and continued patent prosecution. The use of proceeds is detailed in the Private Placement Memorandum and may be updated for subsequent closings.
The company's primary exit pathway is a strategic acquisition by a major agricultural input company (Bayer, BASF, Corteva, Syngenta) or a private equity-led rollup of the facility portfolio. A secondary pathway is an IPO or SPAC combination at the $1B+ valuation level. The 5-year timeline to Y5 revenue of $900M and $4.95B valuation is designed to create an attractive acquisition target. No exit is guaranteed.
Yes. Qualified accredited investors who request materials through this page will receive access to the full investor data room, which includes university trial reports, USDA correspondence, commercial farm performance data, audited financials, and the full Private Placement Memorandum. The data room is provided under NDA after accreditation verification. Schedule a call with our investor relations team to begin the qualification process.
The question isn't whether the world needs it.
It's whether you invest before it scales.
It's whether you invest before it scales.
Step 1 of 4
Are you an accredited investor?
Per SEC Rule 501, an accredited investor has a net worth exceeding $1M (excluding primary residence) or annual income above $200K ($300K joint) for the past two years.
This communication is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities. Any such offer or solicitation will be made only through the Private Placement Memorandum to accredited investors in compliance with applicable securities laws. Investing involves risk, including loss of principal. Past performance does not guarantee future results.